Certified by Founder Lodge
Clarke Capital Partners
United States - Provo
INVESTOR
1 Disclosed Funding Rounds $10,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Private Investment Firm Focused on Alternative Assets Classses, including Growing Companies normally producing $1-$5 MM of EBITDA with Solid Management Teams and Defensible Business Strategie
Company | Date | Round | Raised |
---|---|---|---|
Biolexis Therapeutics, Inc. | November, 30 ,2023 | Series A | $10,000,000 |